Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients.
about
Potential Roles of Adropin in Central Nervous System: Review of Current LiteratureAlzheimer's Disease associated with Psychiatric ComorbiditiesLithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascadeSecond messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part II: bipolar disorderAdverse drug reaction prediction using scores produced by large-scale drug-protein target docking on high-performance computing machinesEffect of Bcl-2 rs956572 SNP on regional gray matter volumes and cognitive function in elderly males without dementia.DNA methylation of BDNF as a biomarker of early-life adversityDecreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disordersTargeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorderRETRACTED: Dose-dependent changes in neuroinflammatory and arachidonic acid cascade markers with synaptic marker loss in rat lipopolysaccharide infusion model of neuroinflammationCoordinated gene expression of neuroinflammatory and cell signaling markers in dorsolateral prefrontal cortex during human brain development and aging.State-related alterations of gene expression in bipolar disorder: a systematic review.Upregulated expression of brain enzymatic markers of arachidonic and docosahexaenoic acid metabolism in a rat model of the metabolic syndromeThe role of BDNF as a mediator of neuroplasticity in bipolar disorder.The Bcl-2 gene polymorphism rs956572AA increases inositol 1,4,5-trisphosphate receptor-mediated endoplasmic reticulum calcium release in subjects with bipolar disorder.Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: relevance to valproate's efficacy against bipolar disorderTranscriptional evidence for the role of chronic venlafaxine treatment in neurotrophic signaling and neuroplasticity including also Glutamatergic [corrected] - and insulin-mediated neuronal processes.Partial rodent genetic models for bipolar disorder.Bax inhibitor 1, a modulator of calcium homeostasis, confers affective resilience.Evidence demonstrating role of microRNAs in the etiopathology of major depressionDisturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex.Chronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats.Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat brain: implications for its efficacy in bipolar disorderRegulation of rat brain polyunsaturated fatty acid (PUFA) metabolism during graded dietary n-3 PUFA deprivation.Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans.Genetic association of the EGR2 gene with bipolar disorder in KoreaValnoctamide, a non-teratogenic amide derivative of valproic acid, inhibits arachidonic acid activation in vitro by recombinant acyl-CoA synthetase-4Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients.Gabapentin's minimal action on markers of rat brain arachidonic acid metabolism agrees with its inefficacy against bipolar disorder.Effects of chronic clozapine administration on markers of arachidonic acid cascade and synaptic integrity in rat brainChronic lithium feeding reduces upregulated brain arachidonic acid metabolism in HIV-1 transgenic rat.Neuroinflammation and synaptic lossChronic clozapine reduces rat brain arachidonic acid metabolism by reducing plasma arachidonic acid availability.Bcl-2 rs956572 polymorphism is associated with increased anterior cingulate cortical glutamate in euthymic bipolar I disorder.Altered neuronal markers following treatment with mood stabilizer and antipsychotic drugs indicate an increased likelihood of neurotransmitter release.Propylisopropylacetic acid (PIA), a constitutional isomer of valproic acid, uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: a potential drug for bipolar disorderComparing clinical responses and the biomarkers of BDNF and cytokines between subthreshold bipolar disorder and bipolar II disorderElevated Monoamine Oxidase-A Distribution Volume in Borderline Personality Disorder Is Associated With Severity Across Mood Symptoms, Suicidality, and CognitionSynaptic abnormalities in the infralimbic cortex of a model of congenital depression.Upstream Pathways Controlling Mitochondrial Function in Major Psychosis: A Focus on Bipolar Disorder
P2860
Q26742073-1D154FDF-E3D9-4E32-BB73-0667F246012AQ26796602-02E27169-F032-4333-9FF3-84E504BF4ECEQ26850084-386F9460-B043-4CF4-B256-4A56071D9768Q27002419-CB2DD9E0-CE12-4D94-8BAC-9B37FE1840CAQ28542829-4F85AD19-4124-4D83-BFB6-CFA4C55047ACQ30537355-08F7B0B1-3B3D-4D08-852E-30F7C337F11CQ30653771-4AF66169-1D65-4CAB-82B0-B307BE7C188CQ33672712-C45B4979-3698-4734-9FFE-858423C6E340Q34268156-F775FBEA-13BC-4592-8ABF-E1A3D558D93FQ34279077-A2177380-9CAC-4B6F-8C1F-E9224042CBBEQ34374526-DF8AE4DF-F6FF-497F-94EC-2D5DA7CFB4E3Q34436227-0BAF69AD-05F5-43DC-B681-C63B980AD71EQ34461400-71450C90-569C-4082-B425-729F5F2D78E6Q34497541-1D7F16FC-F38E-4BC3-B25F-6EB75561C14CQ34557784-EA618FF3-7717-4F90-8B94-C328DF1271BBQ34566029-D2BA6C7E-55D8-4D35-AD9D-59172A00E722Q34571919-0828FE52-CFFD-49F1-80AC-000E3FC722F8Q34907675-9B8BCFC0-8429-425E-85E3-B0C2A910973BQ35098811-31CD7CEE-087A-48DB-934E-43A9AAE9CD2AQ35186527-0D1C7EE8-4F59-41F0-BA6D-4372B9A8044BQ35218379-E1F5E0B1-52CF-4689-9E33-FB1B7F5AB1F7Q35308508-C5BCB1FE-BCF3-429F-BADD-503FDCDED86AQ35476477-D4BC4A66-4110-43BA-89EA-7CCCC0B58C27Q35529104-11F6666B-568B-428A-8FB6-497E89A7BFFCQ35742545-75FE6D0A-64F3-4C5B-AC2F-ECD11FD80C6EQ35812543-D4C59A5F-37A8-42AB-B341-3519D6C9101FQ36010817-EB5C8F32-EA93-499A-B167-85473814EAECQ36136017-78F7333D-D380-4646-A5B7-6117EA0C2E5DQ36199755-72136024-3406-4244-B89D-9F219C32C9BAQ36338174-70597580-6C74-47A2-987A-C54B88E55723Q36338186-0D9C92C2-A53F-4D23-9A5E-D8D0236F94E2Q36340687-B95496C9-D6E4-4E22-91D2-4D0370C11757Q36518167-686BABDB-8D7E-4EC2-8FEE-010A72109CBDQ36540042-952161B1-8929-4463-AEDC-5CCC979BD2B8Q36600830-2B6DF801-D686-47CD-A884-5AD1BD2527BEQ36673587-7946BA4A-6B00-446A-B15E-89E47F282878Q36974468-D494B249-19BF-49AE-8FEA-F7789CF0DA73Q37088430-9012243F-F4B3-49EA-B4E1-2F047267A605Q37093894-269866C5-C6F3-4DC1-A3ED-B29562EC242FQ37123412-65761699-AA93-4C09-95A6-590EAF048DE7
P2860
Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Altered expression of apoptoti ...... rom bipolar disorder patients.
@ast
Altered expression of apoptoti ...... rom bipolar disorder patients.
@en
type
label
Altered expression of apoptoti ...... rom bipolar disorder patients.
@ast
Altered expression of apoptoti ...... rom bipolar disorder patients.
@en
prefLabel
Altered expression of apoptoti ...... rom bipolar disorder patients.
@ast
Altered expression of apoptoti ...... rom bipolar disorder patients.
@en
P2860
P1476
Altered expression of apoptoti ...... rom bipolar disorder patients.
@en
P2093
Hyung-Wook Kim
Jagadeesh S Rao
P2860
P304
P356
10.1016/J.NBD.2009.11.010
P577
2009-11-26T00:00:00Z